The Perspective of Vitamin D on suPAR-Related AKI in COVID-19
The coronavirus disease 2019 (COVID-19) pandemic has claimed the lives of millions of people around the world. Severe vitamin D deficiency can increase the risk of death in people with COVID-19. There is growing evidence that acute kidney injury (AKI) is common in COVID-19 patients and is associated...
Main Authors: | Tzu-Hsien Liao, Hsien-Chang Wu, Min-Tser Liao, Wan-Chung Hu, Kuo-Wang Tsai, Ching-Chieh Lin, Kuo-Cheng Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/18/10725 |
Similar Items
-
suPAR, a Circulating Kidney Disease Factor
by: Changli Wei, et al.
Published: (2021-10-01) -
The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
by: Maurizio Benucci, et al.
Published: (2022-12-01) -
suPAR as a marker of infection in acute kidney injury – a prospective observational study
by: Anna Hall, et al.
Published: (2018-08-01) -
Kinetics of SuPAR hemoadsorption in critical COVID-19 patients on renal replacement therapy
by: Vaidas Vicka, et al.
Published: (2022-11-01) -
Reassessing the Reassessment of suPAR in glomerular disease
by: Björn eMeijers, et al.
Published: (2015-01-01)